Taiwan Liposome Company, Ltd. - ADRs (TLC): Price and Financial Metrics
TLC Price/Volume Stats
| Current price | $7.00 | 52-week high | $7.70 |
| Prev. close | $7.00 | 52-week low | $4.07 |
| Day low | $7.00 | Volume | 12,400 |
| Day high | $7.09 | Avg. volume | 133,095 |
| 50-day MA | $7.06 | Dividend yield | N/A |
| 200-day MA | $5.88 | Market Cap | 294.54M |
TLC Stock Price Chart Interactive Chart >
Taiwan Liposome Company, Ltd. - ADRs (TLC) Company Bio
Taiwan Liposome Company, Ltd. is a Taiwan-based company principally engaged in the research and development and commercialization of lipid drug delivery systems. The Company is engaged in the development of special generic drugs, new formulas and new drugs using patents. The Company's therapeutic areas include pain management, eye diseases and cancer. Its anticancer medicine product named Lipo-Dox has been distributed in domestic and Asian markets.
TLC Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 42.42% |
| YTD | N/A |
| 2024 | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | -17.66% |
Continue Researching TLC
Want to see what other sources are saying about Taiwan Liposome Company Ltd's financials and stock price? Try the links below:Taiwan Liposome Company Ltd (TLC) Stock Price | Nasdaq
Taiwan Liposome Company Ltd (TLC) Stock Quote, History and News - Yahoo Finance
Taiwan Liposome Company Ltd (TLC) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...